New Cautions About Long-Term Use of Bone Drugs

In an unusual move that may prompt millions of women to rethink their use of popular bone-building drugs, the FDA published an analysis that suggested caution about long-term use of the drugs, but fell short of issuing specific recommendations.
The New York Times